MORGAN STANLEY - FULCRUM THERAPEUTICS INC ownership

FULCRUM THERAPEUTICS INC's ticker is FULC and the CUSIP is 359616109. A total of 112 filers reported holding FULCRUM THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.07 and the average weighting 0.3%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of FULCRUM THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$4,048,708
+11.1%
911,871
-17.4%
0.00%
Q2 2023$3,642,785
+10.0%
1,103,874
-5.0%
0.00%
Q1 2023$3,312,749
-61.2%
1,162,368
-1.0%
0.00%
-100.0%
Q4 2022$8,543,888
-12.0%
1,173,611
-2.2%
0.00%0.0%
Q3 2022$9,711,000
+68.1%
1,200,302
+1.8%
0.00%0.0%
Q2 2022$5,776,000
-78.0%
1,178,956
+6.4%
0.00%
-75.0%
Q1 2022$26,215,000
+1555.0%
1,108,424
+1137.8%
0.00%
Q4 2021$1,584,000
-33.9%
89,550
+5.3%
0.00%
Q3 2021$2,398,000
+216.8%
85,011
+17.6%
0.00%
Q2 2021$757,000
-5.3%
72,296
+6.6%
0.00%
Q1 2021$799,000
-31.0%
67,805
-31.4%
0.00%
Q4 2020$1,158,000
+361.4%
98,898
+212.5%
0.00%
Q3 2020$251,000
-66.6%
31,649
-22.9%
0.00%
Q2 2020$751,000
+115.8%
41,050
+40.8%
0.00%
Q1 2020$348,000
+54.0%
29,148
+114.1%
0.00%
Q4 2019$226,000
+882.6%
13,616
+294.3%
0.00%
Q3 2019$23,0003,4530.00%
Other shareholders
FULCRUM THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
TRV GP III, LLC 3,962,202$19,415,0007.94%
TRV GP IV, LLC 2,343,154$11,481,0007.55%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 949$193,741,0002.02%
Logos Global Management LP 1,950,000$9,555,0001.75%
COWEN AND COMPANY, LLC 2,385,885$11,691,0001.13%
SUVRETTA CAPITAL MANAGEMENT, LLC 3,355,624$16,443,0000.62%
ACUTA CAPITAL PARTNERS, LLC 200,000$980,0000.55%
RTW INVESTMENTS, LP 3,961,194$19,410,0000.50%
Parkman Healthcare Partners LLC 262,689$1,287,0000.47%
Deep Track Capital, LP 1,000,000$4,900,0000.32%
View complete list of FULCRUM THERAPEUTICS INC shareholders